Latest Research Highlights

Basic Dilantin Information

• INN (International Nonproprietary Name): Phenytoin
• Brand Names Available In Canada (English): Dilantin, Dilantin-30, Dilantin-125, Dilantin Infatabs
• ATC Code: N03AB02
• Forms & Dosages: Capsules (30 mg, 100 mg); Chewable Tablets (50 mg, 100 mg); Oral Suspension (125 mg/5 mL); Injectable Solution (50 mg/mL)
• Manufacturers In Canada (English): Pfizer Canada
• Registration Status In Canada (English): Registered; prescription-only products listed under Canadian brands
• OTC / Rx Classification: Prescription Only (Rx)

What has changed since 2022 about dilantin safety and monitoring that matters to patients in Canada?

Research since 2022 has emphasised real‑world phenytoin safety, therapeutic‑drug‑monitoring strategies and comparative effectiveness versus newer agents.

Canadian observational cohorts and pharmacoepidemiology reports have tracked hospital readmissions for phenytoin toxicity and drug‑interaction complications.

International meta‑analyses highlighted phenytoin’s predictable seizure control in tonic‑clonic and focal seizures but higher adverse‑event rates than levetiracetam in some populations.

Key themes are a narrow therapeutic index, enzyme induction contributing to polypharmacy risks, and pregnancy counselling due to teratogenic signals balanced against seizure risk.

Data Highlights:

• Therapeutic Range: Total phenytoin commonly monitored at 10–20 µg/mL.
• Common Adverse Events: Nystagmus, ataxia, gum overgrowth, rash, dizziness, liver enzyme elevations, blood dyscrasias.
• Monitoring Frequency: Check levels at steady state after dose changes and as clinically indicated; consider free phenytoin in hypoalbuminaemia.

Patient‑Centred Takeaways For Canada:

Accessible blood‑level testing is available through provincial labs and many hospital labs across Canada.

Remote monitoring and telehealth help bridge gaps in rural and Indigenous communities where timely phenytoin assays can be harder to arrange.

Bilingual patient materials and counselling (English and French) improve understanding and adherence for diverse Canadian patients.

Health Canada has maintained labelled safety information consistent with FDA and EMA communications on monitoring and interactions.

Common search terms patients use include dilantin, phenytoin therapeutic levels, phenytoin safety and drug monitoring.

Clinical Effectiveness In Canada

Is phenytoin effective for typical seizure types seen in Canadian clinics?

Health Canada supports phenytoin (INN: phenytoin) as an effective antiepileptic for tonic‑clonic and partial seizures.

Phenytoin appears on some provincial formularies with DIN listings for branded and generic formulations.

Clinicians continue to use phenytoin when other agents are unsuitable due to cost, comorbidity or specific seizure types.

Data Highlights:

• ATC: N03AB02.
• Canadian Brand Names: Dilantin, Dilantin‑30, Dilantin‑125, Dilantin Infatabs in capsule, chewable and suspension forms.
• Routine Monitoring: Serum phenytoin assays and baseline labs are routine for long‑term therapy.

Patient Access Factors:

DIN on packaging is required for many reimbursement claims across provincial drug plans.

Community pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs routinely dispense phenytoin and offer counselling.

Clinicians should balance efficacy against interaction profile and monitoring burden when selecting therapy.

Indications And Expanded Uses

What are the approved uses and the rare off‑label roles of phenytoin in Canadian practice?

Approved Canadian indications align with international labels for tonic‑clonic (generalised) seizures and focal (partial) seizures.

Short‑term prophylaxis in neurosurgical contexts is also part of usual clinical practice when indicated.

Approved Indications

Typical Dose: Adult usual 100 mg three times daily, titrated by blood level and clinical response.

Off‑Label Uses

Neuropathic pain or emergent arrhythmia management in specific settings; evidence level is limited and specialist oversight is required.

Standard Dosing References From Real Data:

Adults frequently start at 100 mg three times daily, with adjustments guided by clinical effect and phenytoin levels.

Children often start at 5 mg/kg/day divided into 2–3 doses and adjust to maintenance of 4–8 mg/kg/day.

Clinical Decision Points In Canada:

Document the indication on prescriptions when seeking reimbursement under provincial formularies that use DIN listings.

Discuss teratogenic risks with patients of childbearing potential and involve neurology and obstetrics for planning.

For perioperative IV prophylaxis, hospitals often prefer IV formulations or fosphenytoin where available per local policy.

Provide bilingual consent materials and coordinate specialist referrals for rural patients.

Composition And Brand Landscape

What is in the bottle and who makes it in Canada?

Active ingredient is phenytoin, commonly as phenytoin sodium.

• Common Canadian Brand Names: Dilantin, Dilantin‑30, Dilantin‑125, Dilantin Infatabs.
• Available Forms: Capsules, chewable tablets and 125 mg/5 mL oral suspension.
• Global And Local Suppliers: Pfizer Canada supplies branded product; generics are supplied internationally by Mylan (Viatris), Teva and Sandoz.

Patient Practical Notes:

Generic substitution is common in community pharmacies, though prescribers can request brand‑specific supply when clinically justified for bioavailability concerns.

Bilingual labelling and clear DIN placement are regulatory requirements in Canada and support reimbursement processing.

Pharmacists should check provincial drug bulletins for preferred suppliers and shortage notices.

Contraindications And Special Precautions

Who should not take dilantin and what warning signs matter?

Absolute contraindications include known hypersensitivity to phenytoin or other hydantoins and co‑administration with delavirdine.

Severe hepatic impairment requires caution, particularly with IV administration.

• Absolute Contraindications: Allergy to phenytoin or hydantoins; co‑administration with delavirdine; severe hepatic impairment when using IV form.
• Relative Precautions: Pregnancy, renal dysfunction, porphyria, heart conduction abnormalities with IV forms, and diabetes.

Common Adverse Effects From Real Data Include Gum Hyperplasia, Nystagmus, Ataxia, Tremor And Skin Rash.

Watch for severe reactions such as Stevens‑Johnson syndrome, hepatotoxicity and blood dyscrasias and seek urgent care if these occur.

Elderly patients may need lower starting doses and closer monitoring due to reduced clearance.

Coordinate care for Indigenous and remote patients to ensure timely lab monitoring and culturally appropriate counselling.

Dosage Guidelines

How is dosing started and adjusted for different Canadian patient groups?

Adult usual oral dosing is commonly 100 mg three times daily with titration guided by clinical effect and serum levels.

Paediatric initial dosing is 5 mg/kg/day divided into 2–3 doses with maintenance typically 4–8 mg/kg/day.

• Practical Tips: Take doses at consistent times each day.
• Use chewable tablets or suspension for paediatric dosing and confirm conversions when switching forms.
• Monitor baseline CBC and LFTs before and during therapy as clinically indicated.

Interactions Overview

Which medicines and habits commonly clash with phenytoin in Canadian practice?

Phenytoin is a potent inducer of cytochrome P450 enzymes and causes wide‑ranging interactions.

Lifestyle Interactions To Note:

• Avoid heavy or binge alcohol use because it can worsen sedation and destabilise levels.
• Maintain consistent meal timing and protein intake to reduce variability in levels.

Health Canada interaction advisories recommend specialist consultation when initiating or stopping interacting drugs.

Cultural Perceptions And Patient Habits

What do Canadian patients say about taking dilantin and how does geography affect care?

Patients commonly report concerns about gum hyperplasia, cosmetic effects and the monitoring burden on public forums and support groups.

Canadians expect clear bilingual information and support through public healthcare and community pharmacies.

Urban patients often access neurologists and labs faster, while rural and Indigenous communities face delays for serum testing and specialist referrals.

• Common Patient Concerns: Side effects, stigma, fertility and pregnancy worries, adherence with multiple daily dosing.
• Pharmacy Access: Major chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu provide counselling and dose conversion support.

Clinicians should provide bilingual written information, involve family or community supports where appropriate, and respect Indigenous cultural practices when planning monitoring schedules.

Availability And Pricing Patterns

Where do Canadians get dilantin and how much might it cost out of pocket?

Phenytoin is prescription‑only and distributed through community chains and hospital pharmacies across Canada.

Pfizer Canada supplies branded Dilantin while generics are available from common international manufacturers via Canadian distribution.

Cross‑Border Notes:

While U.S. generic prices can sometimes be lower, importation is regulated and prescriptions are required.

Check customs rules and provincial reimbursement eligibility before attempting cross‑border purchase.

Online Canadian pharmacies that ship domestically require a valid prescription and should be licenced by provincial authorities.

Patient Advice:

Confirm the DIN on packaging, ask the dispensing pharmacist about generic substitution and check provincial formulary criteria to estimate out‑of‑pocket costs.

Comparable Medicines And Preferences

What alternatives are commonly used in Canada and how do they compare to dilantin?

Common alternatives include carbamazepine, valproic acid, levetiracetam and lamotrigine.

Clinical Selection Considerations In Canada:

Balance efficacy, interaction profile, pregnancy plans and monitoring burden.

In settings with limited lab access, clinicians often favour agents with wider therapeutic windows and simpler monitoring requirements, though payers and formulary coverage influence choices.

Shared decision‑making and bilingual resources help patients understand trade‑offs when switching therapy.

FAQ Common Canadian Patient Questions

Can I buy dilantin without a prescription in Canada?

No. Phenytoin is prescription‑only in Canada and pharmacies require a valid prescription and DIN for reimbursement.

How often are blood levels checked?

Check phenytoin at steady state after dose changes, then as clinically indicated.

Typical target total phenytoin is 10–20 µg/mL and consider free phenytoin in hypoalbuminaemia.

Will phenytoin affect my birth control?

Yes. Enzyme induction can reduce the effectiveness of hormonal contraception.

Discuss alternative contraceptive methods or additional barrier protection with the prescriber and pharmacist.

Is dilantin covered by provincial plans?

Coverage depends on specific DIN listings and provincial formularies such as ODB, BC PharmaCare and RAMQ.

Check with your dispensing pharmacy for coverage details.

What if I live in a rural area and can’t get blood tests quickly?

Coordinate with community health centres for scheduled draws and use telemedicine to consult neurology when needed.

Consider agents with less frequent monitoring only after specialist discussion.

• Quick Actions: Call your pharmacist, bring a complete medication list and ask about the DIN on bottle labels for coverage questions.

Guidelines For Proper Use

What should pharmacists and prescribers do at dispensing and discharge to keep patients safe?

Confirm the indication, check DIN and verify formulation (capsule, chewable, suspension) before dispensing.

Reconcile all medications to catch interactions and counsel on consistent dosing times and not stopping abruptly.

• Discharge Counselling Checklist:
• Explain dosing schedule and what to do with missed doses.
• Advise reporting rash, fever, gum changes or unusual bleeding immediately.
• Arrange baseline CBC, LFTs and a phenytoin level at steady state.

Provincial Authority Tips:

Include indication on prescriptions to assist reimbursement and use provincial lab services for timely assays.

Flag high‑risk patients such as pregnant people, elderly and those with hepatic disease for specialist follow‑up.

For remote communities, align blood draw schedules with local clinics and liaise with provincial telemedicine neurology services.

Provide bilingual patient leaflets and document DIN to support pharmacy substitution and claims.

Delivery Across Canada (English)

Final Practical Notes For Patients:

Phenytoin is prescription‑only and should be used under medical supervision per provincial and Health Canada guidance.

Ask your pharmacist about the DIN on your bottle, options for generic substitution and steps for arranging timely blood testing.

If you are pregnant or planning pregnancy, speak with neurology and obstetrics to balance seizure control and fetal safety.

Keep a current medication list when visiting any pharmacy and report any new symptoms such as rash, fever or unusual bleeding immediately.

For help finding a licensed Canadian online pharmacy that dispenses prescription medications, contact your provincial college of pharmacists for a verified provider.